- ISIN
- US71535D1063
- CUSIP
- 71535D106
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- IPO Date
- Jun 20, 2019
Highlights
- Market Cap
- $1.06B
- Enterprise Value
- $1.02B
- EPS (TTM)
- -$1.02
- Total Revenue (TTM)
- $49.04M
- Gross Profit (TTM)
- -$6.62M
- EBITDA (TTM)
- -$90.09M
- Year Range
- $3.84 - $12.53
- Target Price
- $12.00
- ROA (TTM)
- -29.36%
- ROE (TTM)
- -37.51%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
PSNL Performance Chart
Personalis, Inc. (PSNL) is up 27.8% since the beginning of the year. At $10 per share, PSNL is trading 18.8% below its 52-week high of $13. Investors who bought $1,000 worth of PSNL shares 5 years ago would now be looking at an investment worth $386.
Loading charts...
Returns By Period
Personalis, Inc. (PSNL) has returned 27.76% so far this year and 58.41% over the past 12 months.
Personalis, Inc.
- 1D
- -3.51%
- 1M
- 20.07%
- YTD
- 27.76%
- 6M
- 16.63%
- 1Y
- 58.41%
- 3Y*
- 72.54%
- 5Y*
- -17.34%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
PSNL Monthly Returns History
Based on dividend-adjusted daily data since Jun 20, 2019, PSNL's average daily return is +0.14%, while the average monthly return is +2.79%. At this rate, an investment would double in approximately 2.1 years.
Historically, 44% of months were positive and 56% were negative. The best month was Jul 2024 with a return of +194.9%, while the worst month was Jan 2024 at -36.2%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 6 months.
On a daily basis, PSNL closed higher 47% of trading days. The best single day was Jul 19, 2024 with a return of +57.1%, while the worst single day was Jul 22, 2024 at -22.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 17.71% | -3.31% | -29.69% | -13.34% | 106.52% | -10.79% | 27.76% | ||||||
| 2025 | -9.69% | -20.69% | -15.22% | 7.69% | 22.49% | 41.68% | -16.46% | -10.77% | 33.33% | 47.85% | 11.31% | -25.82% | 37.72% |
| 2024 | -36.19% | 15.67% | -3.87% | -1.34% | -11.56% | -10.00% | 194.87% | 57.68% | -1.10% | -6.13% | -21.39% | 45.59% | 175.24% |
| 2023 | 18.69% | 28.09% | -8.31% | -17.39% | -21.05% | 4.44% | 25.53% | -22.88% | -33.52% | -20.48% | 59.01% | 37.25% | 6.06% |
| 2022 | -20.18% | -7.81% | -22.00% | -31.62% | -29.29% | -12.88% | 6.96% | -10.30% | -10.27% | -10.10% | -4.87% | -22.05% | -86.12% |
| 2021 | 5.08% | -19.86% | -20.18% | 0.12% | -8.73% | 12.49% | -17.04% | 0.91% | -9.16% | 1.98% | -30.94% | 5.31% | -61.02% |
Benchmark Metrics
Personalis, Inc. has an annualized alpha of 8.19%, beta of 1.71, and R2 of 0.12 versus S&P 500 Index. Calculated based on daily prices since June 20, 2019.
- This stock participated in 193.27% of S&P 500 Index downside but only 120.84% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.12 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 8.19%
- Beta
- 1.71
- R²
- 0.12
- Upside Capture
- 120.84%
- Downside Capture
- 193.27%
Return for Risk
Risk / Return Rank
PSNL ranks 64 for risk / return — better than 64% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Personalis, Inc. (PSNL) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PSNL | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.40 | ||
| Sortino ratioReturn per unit of downside risk | -1.27 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.37 | -0.18 |
| Calmar ratioReturn relative to maximum drawdown | 1.06 | 2.78 | -1.72 |
| Martin ratioReturn relative to average drawdown | 2.17 | 12.44 | -10.27 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Personalis, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Personalis, Inc. was 98.18%, occurring on Oct 23, 2023. The portfolio has not yet recovered.
The current Personalis, Inc. drawdown is 80.07%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2023 bear market2023 | -98.18%Oct 2023 | 2y 9mo | — | 5y 5moJan 2021 - now |
COVID crash2020 | -84.30%Mar 2020 | 8mo 26d | 6mo 27d | 1y 3moJun 2019 - Oct 2020 |
2021 bear market2021 | -25.91%Jan 2021 | 14d | 13d | 27dDec 2020 - Jan 2021 |
2020 correction2020 | -19.50%Nov 2020 | 21d | 18d | 1mo 9dOct 2020 - Nov 2020 |
2020 correction2020 | -18.45%Nov 2020 | 1d | 13d | 14dNov 2020 - Dec 2020 |
Drawdown Indicators
| PSNL | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.18% | -56.78% | -41.40% |
Max Drawdown (1Y)Largest decline over 1 year | -55.20% | -9.10% | -46.10% |
Max Drawdown (3Y)Largest decline over 3 years | -60.59% | -18.90% | -41.69% |
Max Drawdown (5Y)Largest decline over 5 years | -96.65% | -25.43% | -71.22% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -80.07% | -1.80% | -78.27% |
Average DrawdownAverage peak-to-trough decline | -75.73% | -10.71% | -65.02% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 27.01% | 2.03% | +24.98% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Personalis, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Personalis, Inc. is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for PSNL relative to other companies in the Diagnostics & Research industry. Currently, PSNL has a P/S ratio of 19.4. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PSNL in comparison with other companies in the Diagnostics & Research industry. Currently, PSNL has a P/B value of 4.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with PSNL
Add Personalis, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with PSNL